PRESS RELEASES
Intas Pharma Announces Settlement and License Agreement With Roche for XELODA®
AHMEDABAD, India, June 25, 2013 /PRNewswire/ --
Intas Pharmaceuticals Ltd. and its wholly owned subsidiary Accord Healthcare Inc., today announced that it has entered into a settlement and license agreement with Hoffmann-La Roche Inc. that will resolve pending patent litigation related to XELODA(R)Tablets, 150 mg and 500 mg, known generically as Capecitabine Tablets. This product is an orally administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers.
XELODA(R) Tablets had U.S. sales of approximately $706.2 million for the 12 months ending Dec 31, 2012, according to IMS Health.
Hoffmann-La Roche Inc. had filed patent infringement suit against Accord Healthcare and Intas Pharmaceuticals Ltd. following Accord's submission to the U.S. Food and Drug Administration of an Abbreviated New Drug Application (ANDA) for a generic version of XELODA(R) Tablets.
As part of the agreement, Hoffman La Roche Inc. has granted Accord a license to enter the U.S. market with a generic version of XELODA(R) Tablets ahead of its exclusivity period. Pursuant to the agreement, pending litigation would be dismissed. All other terms and conditions of the settlement are confidential, and the agreement itself is subject to review by the U.S. Department of Justice and the Federal Trade Commission.
About XELODA
XELODA(R), an oral tablet formulation of capecitabine, is approved in U.S. for the treatment of metastatic breast and colorectal cancers. It is available in dose strengths of 150 and 500 mg.
About Intas Pharmaceuticals Limited:
Intas Pharmaceuticals Limited is a leading vertically integrated Indian pharmaceutical company committed on delivering affordable and innovative pharmaceutical solutions. Its operation range from API to formulation development to large-scale commercial manufacturing to cater to global requirements In the domestic market Intas has a leading presence in chronic therapeutic segments and is currently ranked 12th largest company. Intas also has extensive presence in more than 60 countries worldwide with robust sales, marketing and distribution infrastructure in highly regulated markets like North America, Europe, South Africa, Australia and New Zealand etc. For the financial year ending March 2013, company has recorded turnover exceeding USD 650 mn. The company has a revenue growth of ~25% CAGR over the last 6 years. www.intaspharma.com [http://www.intaspharma.com ]
About Accord Healthcare Inc:
Accord Healthcare, Inc is the wholly owned subsidiary of Intas in the US. Accord has been servicing the needs of the US healthcare industry since 2009. Its US portfolio consists of about 30 approved oral solids and injectable prescription medicines and 38 awaiting USFDA approval. Accord is now the second largest Indian player in the US generic injectable space.
Primary Media Contact: Pritesh Trivedi, priteshtrivedi@oneadvt.com, 91-97272-60309
Secondary Media Contact: Gaurang Darji, gaurangdarji@oneadvt.com, 91-99250-38960
Indian Railway to launch this 'SUPER APP', passengers can now..., know details here
Who is Rashmi Shukla, IPS officer whom EC removed as Maharashtra DGP?
This village in India allows men to have two wives, living under one roof due to…
AUS vs PAK, 1st ODI: Australia beat Pakistan by 2 wickets to take 1-0 lead in series
Singham Again’s sole aim is to entertain, it’s not a Hindutva propaganda
Delhi pollution: 'Why firecracker ban was not implemented during Diwali,' SC asks police, govt
IPL 2025 mega auction likely to be held in Riyadh on these dates
Big update on Reliance Jio IPO as Mukesh Ambani eyes THIS date
EC reschedules UP, Punjab, Kerala bypolls from Nov 13 to...
Coldplay's Chris Martin falls through stage trap door while performing live in Australia
Meet man, who is rising star in Tata Group after Ratan Tata's death, now tasked with...
'Nice handwriting': Internet reacts to Elon Musk's physics homework from his college days
Mithun Chakraborty's first wife Helena Luke dies at 68
AIIMS INI CET 2025 admit card releasing today at aiimsexams.ac.in; when and how to download
Sustainability Meets Innovation via uPVC: Industry expert shares experience
Promoting innovation in engineering education
AP TET 2024 exam result declared at aptet.apcfss.in; steps to check
AI-Powered Development: Insights from industry leaders on transforming software engineering
Another BIG move by BSNL, now set to provide tough competition to Jio, Airtel, Vi by...
Bigg Boss 18: Vivian D'Sena accuses Chahat Pandey of pooping on floor, latter loses her cool
Uttarakhand Bus Accident: 36 dead after bus falls into gorge in Almora; rescue operations underway
One of India's best wicketkeepers set to retire after this season, won't play IPL too, he is...
Research shows awe-inspiring details about Black Holes, they can...
US Presidential Election 2024: Harris vs Trump goes down to the wire, say polls
AP TET 2024 exam result to be declared today on aptet.apcfss.in, when and how to check
Shampoo, tea, biscuits, oil to get costlier soon? FMCG firms caution price hike as...
Swiggy fined Rs 35000 for duping Hyderabad customer by doing THIS
Delhi pollution: Air quality in Delhi-NCR further deteriorates, AQI hits 'severe' level
Indian mission condemns attack on Hindu devotees at Canada temple by ‘anti-India’ elements
'Upar se leke neeche tak...': Bigg Boss 18's Kashish Kapoor, Eisha Singh get into ugly spat
Man grows 500 kg pumpkin, uses it as boat to sail 70 km, SEE PIC
Devotees at Banke Bihari Temple drink AC water believing it to be 'Charan Amrit'; WATCH viral video
Bank Holidays in November: Banks to remain closed for four days in THESE states, full list here
Bhool Bhulaiyaa 3: Kartik Aaryan's mother struggles to get tickets, hilarious video goes viral
Mumbai Police arrest Maharashtra woman for hoax death threat to UP CM Yogi Adityanath
Kriti Sanon avoids posing with rumoured boyfriend Kabir Bahia at Mumbai airport, video goes viral
This is world's most expensive house, twice price of Mukesh Ambani's Antilia, it is located in...
SC to hear today Delhi govt's plea against vesting LG with power to appoint...
Viral video: Girl’s sizzling dance to ‘Taareefan’ song earns praise from netizens, watch
Watch: Elderly couple's heartwarming dance at Mohit Chauhan's Patna concert goes viral
This is India’s most expensive wedding card, made from real gold and silver, it costs Rs…
Viral video: Men’s mid-air stunt, twerk on Mumbai local train leaves netizens in splits, watch
Kartik Aaryan reveals details about his new 'girlfriend': 'Her name is...'
Delhi pollution: Air quality worsens in capital, AQI worst in India at...
Singham Again movie review: Ajay Devgn, Akshay Kumar, Ranveer Singh's high octane actioner
Pune: 35-year-old man killed by speeding car while bursting firecrackers on Diwali, video surfaces
Shah Rukh Khan makes BIG revelation on his birthday, says he has quit...
‘Against the principles of…’: Vijay-led TVK passes resolution against One Nation One Election
Watch: Two Delhi traffic police personnel dragged for 20 metres, case filed
Delhi-NCR pollution: Targeted measures enforced under GRAP for 16 days from...
AUS vs PAK Live Streaming: When and where to watch Australia vs Pakistan 1st ODI in India?
Viral video: Man casually lies on Delhi metro floor, leaves netizens divided
'No justification for..' J-K CM Omar Abdullah reacts to Srinagar terrorist attack
Who is Sunil Lulla, on whom Sebi imposed Rs 5000000 fine for violating market norms?
This bank's UPI services will NOT work for two days in November due to...; check details
Arjun Kapoor's Ravana overpowers Ajay Devgn's Rama in Rohit Shetty's Ramayana-inspired Singham Again
Shah Rukh Khan spotted wearing one of the most expensive watches in the world, it costs Rs...
Delhi Pollution: National capital's PM 2.5 Levels 13% higher than previous Diwali, reports suggest